Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **pneumococcal polysaccharide capsule** is a thick, surface-exposed carbohydrate layer that surrounds the cell wall of *Streptococcus pneumoniae*. It is composed of repeating oligosaccharide units that vary among more than 90 serotypes, with each serotype expressing a structurally distinct capsule. The capsule is the primary virulence factor for *S. pneumoniae*, protecting the bacterium from opsonophagocytic killing by interfering with recognition and clearance by the host immune system. Its composition and structure define the immunological serotype, determining susceptibility to vaccine-induced antibodies. The capsule is the principal antigen targeted in current pneumococcal vaccines, which work by inducing serotype-specific antibodies that facilitate bacterial clearance. Serotype shifts and structural variations can reduce vaccine efficacy and complicate epidemiological surveillance[1][3][6].
Vaccines induce anti-capsular antibodies that promote opsonophagocytosis and clearance of Streptococcus pneumoniae[1][6] Vaccines block capsule-mediated immune evasion
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pneumococcal polysaccharide capsule.